Julian Ziegler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Julian Ziegler has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Andreas Neu
Department of Pediatric and Adolescent Medicine University Hospital Tuebingen Tuebingen Germany
4 shared publications- Roland Schweizer
Pediatric Endocrinology and Diabetology, University Children′s Hospital Tübingen, Tübingen, Germany
3 shared publications Klaus Dietz
Department of Medical Biometry University of Tuebingen Tuebingen Germany
2 shared publicationsStefan Ehehalt
Health Department of the City of Stuttgart Stuttgart Germany
2 shared publications- Torben Biester
Department of Pediatric Diabetology, Children’s Hospital Auf der Bult, Hannover, Germany
2 shared publications - Alexandra Schneider
Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
1 shared publication
Latest Publications
- Open Access
- 6 January 2026
- Published by Wiley in Diabetic Medicine
- Vol. 43 (4) , e70215
Age‐specific incidence and prevalence of childhood type 1 diabetes: Development over four decades in Southwest Germany
Aims: This study evaluated the incidence and prevalence of type 1 diabetes in children and adolescents in Baden–Wuerttemberg over 38 years considering various subgroups. Methods: Data were drawn from the German Diabetes Registry (DIARY) for 11,797 children aged <15 years with clinically diagnosed type 1 diabetes. Incidence rates were calculated per 100,000 person‐years and presented as crude, age‐ and sex‐specific rates, including annual percent changes (APC) from 1987 to 2024. Results: In 1987, the crude incidence was 10.1 per 100,000 children per year, rising to 20.2 per 100,000 children per year in 2024. Between 1987 and 2008, the incidence increased steadily at 4.0% annually, followed by a plateau through 2024 despite demographic shifts including declining birth rates and increased immigration. The peak incidence occurred during the COVID‐19 pandemic, reaching 31.1 per 100,000 children per year in 2021, before returning to 20.2 per 100,000 children per year by 2024. The highest subgroup incidence was found in boys aged 10–14 years at 25.4 per 100,000 children per year. A marked increase during the pandemic was seen mainly in children under 10 years. The estimated prevalence as of 31 December 2024 was 0.154%. Conclusions: Incidence rates have doubled since the first documentation in 1987. Since 2008, the rates have remained stable at a high level without further increase. The long‐term trend suggests a levelling off in incidence, with pandemic‐related increases limited primarily to younger children.
- 6 January 2026
- Published by Wiley in Diabetic Medicine
- Vol. 43 (4) , e70215
Open AccessAge‐specific incidence and prevalence of childhood type 1 diabetes: Development over four decades in Southwest Germany
Aims: This study evaluated the incidence and prevalence of type 1 diabetes in children and adolescents in Baden–Wuerttemberg over 38 years considering various subgroups. Methods: Data were drawn from the German Diabetes Registry (DIARY) for 11,797 children aged <15 years with clinically diagnosed type 1 diabetes. Incidence rates were calculated per 100,000 person‐years and presented as crude, age‐ and sex‐specific rates, including annual percent changes (APC) from 1987 to 2024. Results: In 1987, the crude incidence was 10.1 per 100,000 children per year, rising to 20.2 per 100,000 children per year in 2024. Between 1987 and 2008, the incidence increased steadily at 4.0% annually, followed by a plateau through 2024 despite demographic shifts including declining birth rates and increased immigration. The peak incidence occurred during the COVID‐19 pandemic, reaching 31.1 per 100,000 children per year in 2021, before returning to 20.2 per 100,000 children per year by 2024. The highest subgroup incidence was found in boys aged 10–14 years at 25.4 per 100,000 children per year. A marked increase during the pandemic was seen mainly in children under 10 years. The estimated prevalence as of 31 December 2024 was 0.154%. Conclusions: Incidence rates have doubled since the first documentation in 1987. Since 2008, the rates have remained stable at a high level without further increase. The long‐term trend suggests a levelling off in incidence, with pandemic‐related increases limited primarily to younger children.
- 24 December 2025
- Published by American Diabetes Association in Diabetes Care
- Vol. 49 (2) , e21-e23
Is Diabetes Technology Associated With Weight Gain in Children and Adolescents With Type 1 Diabetes?
- 24 December 2025
- Published by American Diabetes Association in Diabetes Care
- Vol. 49 (2) , e21-e23
Is Diabetes Technology Associated With Weight Gain in Children and Adolescents With Type 1 Diabetes?
- 12 August 2025
- Published by American Diabetes Association in Diabetes Care
- Vol. 48 (10) , e122-e123
Incidence of Type 1 Diabetes in Children Before, During, and After the COVID-19 Pandemic: 38-Year Analysis in Southwest Germany
- 12 August 2025
- Published by American Diabetes Association in Diabetes Care
- Vol. 48 (10) , e122-e123
Incidence of Type 1 Diabetes in Children Before, During, and After the COVID-19 Pandemic: 38-Year Analysis in Southwest Germany
- Open Access
- 1 January 2025
- Published by Wiley in Pediatric Diabetes
- Vol. 2025 (1) , 4717290
Celiac Disease in Children With Type 1 Diabetes: The Usefulness of Screening— 25 years of Experience in a Single Center
Objective: Children with type 1 diabetes (T1D) have an increased risk of developing additional autoimmune diseases. The risk of developing celiac disease (CD) is 3–4 times higher in children with T1D. Guidelines recommend regular screening for transglutaminase antibodies (TgAbs) in T1D children. CD could be an additional burden for T1D children as both diseases affect food intake. We describe the screening practice for CD during the last 25 years in our outpatient clinic in children with T1D. Methods: We retrospectively analyzed the development of CD‐specific antibodies in our children with T1D (diabetes onset since 1998). We did not routinely recommend endoscopy when CD‐specific antibodies (TgAb, endomysium [EAb], and gliadin) were positive and patients had no CD‐specific symptoms. Results: We analyzed 304 patients. In total 122 had CD‐specific antibodies. In 98 of them, they disappeared after a short time or had been only slightly elevated. The diagnosis of CD was confirmed in 12. All 12 showed CD‐specific symptoms, such as failure to thrive, anemia, hypoglycemia, or gastrointestinal problems. In six patients, even severely elevated EAb and/or TgAb disappeared on average after 7.1 years (range 4.9–13.5 years) on gluten‐containing diet. The remaining six had antibodies without CD‐specific symptoms by the end of the observation period. In this group the duration of antibody‐positivity was 4 years (range 1.8–11.6 years). Conclusion: We conclude that even highly elevated CD‐specific antibodies can disappear in children with T1D and that screening for CD‐specific antibodies is therefore only useful in symptomatic children with T1D.
- 1 January 2025
- Published by Wiley in Pediatric Diabetes
- Vol. 2025 (1) , 4717290
Open AccessCeliac Disease in Children With Type 1 Diabetes: The Usefulness of Screening— 25 years of Experience in a Single Center
Objective: Children with type 1 diabetes (T1D) have an increased risk of developing additional autoimmune diseases. The risk of developing celiac disease (CD) is 3–4 times higher in children with T1D. Guidelines recommend regular screening for transglutaminase antibodies (TgAbs) in T1D children. CD could be an additional burden for T1D children as both diseases affect food intake. We describe the screening practice for CD during the last 25 years in our outpatient clinic in children with T1D. Methods: We retrospectively analyzed the development of CD‐specific antibodies in our children with T1D (diabetes onset since 1998). We did not routinely recommend endoscopy when CD‐specific antibodies (TgAb, endomysium [EAb], and gliadin) were positive and patients had no CD‐specific symptoms. Results: We analyzed 304 patients. In total 122 had CD‐specific antibodies. In 98 of them, they disappeared after a short time or had been only slightly elevated. The diagnosis of CD was confirmed in 12. All 12 showed CD‐specific symptoms, such as failure to thrive, anemia, hypoglycemia, or gastrointestinal problems. In six patients, even severely elevated EAb and/or TgAb disappeared on average after 7.1 years (range 4.9–13.5 years) on gluten‐containing diet. The remaining six had antibodies without CD‐specific symptoms by the end of the observation period. In this group the duration of antibody‐positivity was 4 years (range 1.8–11.6 years). Conclusion: We conclude that even highly elevated CD‐specific antibodies can disappear in children with T1D and that screening for CD‐specific antibodies is therefore only useful in symptomatic children with T1D.
- 1 April 2023
- Published by Georg Thieme Verlag KG in Diabetologie und Stoffwechsel
- Vol. 18 (S 01) , S54-S55
Häufigkeit und Verteilung von diabetesspezifischen Antikörpern bei Kindern und Jugendlichen mit Typ 1 Diabetes mellitus
Hintergrund Die Zuordnung zum Typ 1 Diabetes mellitus (T1DM) lässt sich durch die Bestimmung von diabetesspezifischen Autoantikörpern bestätigen. Routinemäßig werden 5 verschiedene Antikörper bestimmt. Die Bestimmung multipler Antikörper kostet Geld. In Zeiten knapper Ressourcen könnte die sequentielle Bestimmung der Antikörpern Kosten sparen. Ziel der Analyse war es deshalb, zu untersuchen, welche Antikörper bei Kindern und Jugendlichen mit T1DM wie häufig vorkommen. Methode Bei 200 Kindern und Jugendlichen mit T1DM (85 weiblich, Alter 0,9 bis 16,6 Jahre) wurden bei Manifestation Inselzell-Antikörper (ICA), Glutamat-Decarboxylase-AK (GADA), Tyrosinphosphatase IA-2 Ak (IA-2A) und Insulin-Autoantikörper (IAA) bestimmt. Der Zink-Transporter 8-Antikörper (A-ZT8-A) wurde nur bei wenigen bestimmt und bleibt deshalb unberücksichtigt. Es wurde die Häufigkeit untersucht mit der die Antikörper positiv waren und ob es Geschlechtsunterschiede gibt. Ergebnisse Am häufigsten, bei 176 (88%) fanden sich ICA positiv. Am zweit häufigsten waren IA-2A positiv bei 74,5%. GADA waren bei 70% positiv, IAA bei 49,5%. Von den 24 ICA negativen hatten 14 IA-2A und 10 GADA davon 7 nur GADA. Eine Patientin hatte nur IAA und 3 keinen dieser 4 Antikörper. Signifikante Geschlechtsunterschiede wurden nicht gefunden. Schlussfolgerung Durch die Bestimmung der ICA werden 88% der Patienten mit T1DM erkannt. Durch die zusätzliche Bestimmung von IA-2A werden 95% erkannt und durch die weiter Bestimmung von GADA 98,5%. Durch die sequentielle Bestimmung von diabetesspezifischen Antikörpern (1. ICA, 2. IA-2A, dann GADA) können Kosten gespart werden, dennoch kann die autoimmune Genese des T1DM gesichert werden. Durch die zusätzliche Bestimmung von A-ZT8-A könnten weitere Kinder erkannt werden, die bisher als seronegativ galten. Article published online: 02 May 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 April 2023
- Published by Georg Thieme Verlag KG in Diabetologie und Stoffwechsel
- Vol. 18 (S 01) , S54-S55
Häufigkeit und Verteilung von diabetesspezifischen Antikörpern bei Kindern und Jugendlichen mit Typ 1 Diabetes mellitus
Hintergrund Die Zuordnung zum Typ 1 Diabetes mellitus (T1DM) lässt sich durch die Bestimmung von diabetesspezifischen Autoantikörpern bestätigen. Routinemäßig werden 5 verschiedene Antikörper bestimmt. Die Bestimmung multipler Antikörper kostet Geld. In Zeiten knapper Ressourcen könnte die sequentielle Bestimmung der Antikörpern Kosten sparen. Ziel der Analyse war es deshalb, zu untersuchen, welche Antikörper bei Kindern und Jugendlichen mit T1DM wie häufig vorkommen. Methode Bei 200 Kindern und Jugendlichen mit T1DM (85 weiblich, Alter 0,9 bis 16,6 Jahre) wurden bei Manifestation Inselzell-Antikörper (ICA), Glutamat-Decarboxylase-AK (GADA), Tyrosinphosphatase IA-2 Ak (IA-2A) und Insulin-Autoantikörper (IAA) bestimmt. Der Zink-Transporter 8-Antikörper (A-ZT8-A) wurde nur bei wenigen bestimmt und bleibt deshalb unberücksichtigt. Es wurde die Häufigkeit untersucht mit der die Antikörper positiv waren und ob es Geschlechtsunterschiede gibt. Ergebnisse Am häufigsten, bei 176 (88%) fanden sich ICA positiv. Am zweit häufigsten waren IA-2A positiv bei 74,5%. GADA waren bei 70% positiv, IAA bei 49,5%. Von den 24 ICA negativen hatten 14 IA-2A und 10 GADA davon 7 nur GADA. Eine Patientin hatte nur IAA und 3 keinen dieser 4 Antikörper. Signifikante Geschlechtsunterschiede wurden nicht gefunden. Schlussfolgerung Durch die Bestimmung der ICA werden 88% der Patienten mit T1DM erkannt. Durch die zusätzliche Bestimmung von IA-2A werden 95% erkannt und durch die weiter Bestimmung von GADA 98,5%. Durch die sequentielle Bestimmung von diabetesspezifischen Antikörpern (1. ICA, 2. IA-2A, dann GADA) können Kosten gespart werden, dennoch kann die autoimmune Genese des T1DM gesichert werden. Durch die zusätzliche Bestimmung von A-ZT8-A könnten weitere Kinder erkannt werden, die bisher als seronegativ galten. Article published online: 02 May 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 January 2006
- Published by Institution of Engineering and Technology (IET)
- Vol. 2006, v1-247
An approach towards personalized user interfaces for ambient intelligent home environments
Today's consumer devices are equipped with an enormous number of functions controllable by the user. Therefore, an efficient menu structure is of high interest. Nowadays each device uses its own user interface along with appropriate menu structures. As a result, different devices from different vendors are typically equipped with diverse menu structures and layouts even if they actually have similar functionalities. Thus, the user is typically confronted with inhomogeneous menu structures forcing one to learn the logic behind each structure first, before an efficient interaction with the interface is possible. This paper discusses a novel approach of interaction-structure generation, which represents the first results of our work done within the user interaction oriented task of the EU-IST funded research project Amigo. Further, this work is also based on results we gained out of our inHaus-project. In this work we present an innovative concept for a personalized graphical user interface for AmI (Aml=ambient intelligence) home environments. Functionalities of different devices and software components are bound into one operation concept to give the user the feeling of interacting with one solid system and not with a loosely coupled set of single devices. Therefore, the binding between device and functionality has been removed and device independent menu structures have been introduced. Links between devices and functionalities are only maintained for the sake of execution. The core idea of the presented approach is to automatically provide a consistent interface throughout different environments. This is reached by adapting structure and presentation to personal user preferences. These adaptations help the user to operate unknown AmI environments efficiently and as intuitively as possible. (9 pages)
- 1 January 2006
- Published by Institution of Engineering and Technology (IET)
- Vol. 2006, v1-247
An approach towards personalized user interfaces for ambient intelligent home environments
Today's consumer devices are equipped with an enormous number of functions controllable by the user. Therefore, an efficient menu structure is of high interest. Nowadays each device uses its own user interface along with appropriate menu structures. As a result, different devices from different vendors are typically equipped with diverse menu structures and layouts even if they actually have similar functionalities. Thus, the user is typically confronted with inhomogeneous menu structures forcing one to learn the logic behind each structure first, before an efficient interaction with the interface is possible. This paper discusses a novel approach of interaction-structure generation, which represents the first results of our work done within the user interaction oriented task of the EU-IST funded research project Amigo. Further, this work is also based on results we gained out of our inHaus-project. In this work we present an innovative concept for a personalized graphical user interface for AmI (Aml=ambient intelligence) home environments. Functionalities of different devices and software components are bound into one operation concept to give the user the feeling of interacting with one solid system and not with a loosely coupled set of single devices. Therefore, the binding between device and functionality has been removed and device independent menu structures have been introduced. Links between devices and functionalities are only maintained for the sake of execution. The core idea of the presented approach is to automatically provide a consistent interface throughout different environments. This is reached by adapting structure and presentation to personal user preferences. These adaptations help the user to operate unknown AmI environments efficiently and as intuitively as possible. (9 pages)